Detalles de la búsqueda
1.
A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
BMC Cancer
; 23(1): 1080, 2023 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37946136
2.
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment.
BMC Cancer
; 20(1): 748, 2020 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32778095
3.
Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort.
Br J Cancer
; 121(12): 991-1000, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31719684
4.
Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.
Br J Cancer
; 121(3): 283, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31235866
5.
Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.
Br J Cancer
; 119(8): 950-960, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30318514
6.
Successfully treatment by eribulin in visceral crisis: a case of lymphangitic carcinomatosis from metastatic breast cancer.
BMC Cancer
; 18(1): 839, 2018 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30126360
7.
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients.
Eur Respir J
; 50(2)2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28798088
8.
Improving olaparib exposure to optimize adverse effects management.
Ther Adv Med Oncol
; 16: 17588359241248328, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38665845
9.
FOLFIRI-bevacizumab as a second-line treatment for advanced biliary tract cancer after gemcitabine-based chemotherapy.
Front Oncol
; 13: 1293670, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38098503
10.
Impact of complete surgical staging on survival of patients with early-stage (FIGO I or II) ovarian cancer: Data from the Cote d'Or Registry of Gynecological Cancers from 1998 to 2015.
Bull Cancer
; 110(4): 352-359, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36805207
11.
Immunoscore immune checkpoint using spatial quantitative analysis of CD8 and PD-L1 markers is predictive of the efficacy of anti- PD1/PD-L1 immunotherapy in non-small cell lung cancer.
EBioMedicine
; 92: 104633, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37244159
12.
First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b/2 trial.
Nat Med
; 29(8): 2087-2098, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37563240
13.
Detection of relevant pharmacogenetic information through exome sequencing in oncology.
Pharmacogenomics
; 23(14): 759-770, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36043386
14.
Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network.
Cancers (Basel)
; 14(2)2022 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35053517
15.
MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells.
Cancer Cell
; 40(2): 136-152.e12, 2022 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35051357
16.
Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study.
Eur J Cancer
; 165: 13-24, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35189537
17.
Genomic Instability Is Defined by Specific Tumor Microenvironment in Ovarian Cancer: A Subgroup Analysis of AGO OVAR 12 Trial.
Cancers (Basel)
; 14(5)2022 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35267497
18.
Targeting BRAF and RAS in Colorectal Cancer.
Cancers (Basel)
; 13(9)2021 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34063682
19.
Phase I Dose-Escalation Trial of an Innovative Chemotherapy Regimen Combining a Fractionated Dose of Irinotecan Plus Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Folinic Acid (bFOLFIRINOX-3) in Chemorefractory Metastatic Colorectal Cancer.
Cancers (Basel)
; 13(21)2021 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34771635
20.
Population Pharmacokinetics of Palbociclib in aReal-World Situation.
Pharmaceuticals (Basel)
; 14(3)2021 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33668400